us to differentiate two branches of the PTGS pathway. One branch is activated by replicating viral RNA and is not affected by p25. The second branch can be activated by non replicating RNA of viral or transgene origin and is suppressed by p25. Our analysis indicates that the systemic signal of silencing is produced in this second, p25-sensitive, branch of the pathway and is likely a precursor of the 25 nucleotide RNAs. Figure 2B, panel 3 ), indicating that Rx had no effect either on initiation or systemic spread of PTGS. It seemed likely, therefore, that the failure of systemic silencing to spread out of the PVX-GF-infected stocks was due to a factor, presumably a protein, encoded in the PVX genome.
Results

To test the hypothesis that signaling of PTGS is a systemic anti-viral defense, we designed grafting experiments in which virus
The PVX-Encoded 25 kDa Protein Prevents Systemic Silencing
To determine whether PVX-encoded proteins are able to prevent or interfere with systemic silencing, we carried out experiments with deletion mutants of PVX-GFP (Figure 1 ). These mutant viruses would have been confined to the initially infected cell because they were all defective for the coat protein (CP) that is required for cell-to-cell and long distance movement of PVX. If, as predicted, a PVX-encoded protein prevented systemic silencing, PTGS initiated by the corresponding PVX-GFP mutant would be manifested away from the inoculated cells. In contrast, silencing initiated by PVX-GFP constructs carrying mutations in any other open reading frame (ORF) would be restricted to the inoculated area.
We first tested the ability of PVX-GFP-⌬CP and PVX-GFP-⌬TGB-⌬CP (Figure 1 ) to induce systemic silencing of the GFP transgene. These constructs are similar to the PVX-GFP vector (Figure 1 ), except that there is a deletion in the CP ORFs. In addition to the CP mutation, PVX-GFP-⌬TGB-⌬CP carries a deletion spanning all three ORFs of the triple gene block (TGB). The TGB encodes three proteins that are strictly required, in addition to the CP, for cell-to-cell movement of PVX (Verchot et al., 1998).
In order to generate high titer inocula of these mutant viruses, we used the pBin19 Ti-plasmid vector (Bevan, 1984) , in which the PVX-GFP constructs were coupled to a 35S promoter. Agrobacterium cultures carrying these constructs were infiltrated into leaves of GFP transgenic plants. Transfer of the T-DNA would allow a high proportion of cells inside the infiltrated area to become infected with the movement-defective mutants of PVX-GFP.
At 3 days post inoculation (dpi) with PVX-GFP-⌬CP In principle, the contrasting silencing phenotypes triggered by the PVX-GFP TGB mutants could be a direct effect of p25. Alternatively, there could be an indirect effect if the mutations affected replication or the ability of these mutants to induce PTGS of GFP in the inoculated leaves. To resolve these alternatives, we carried out northern analysis of RNA from the infiltrated leaf tissues at 2.5 and 5dpi, using a GFP-specific probe. The constructs in these experiments were derivatives of PVX-GFP-⌬CP (Figure 1 ), in which a 500nt fragment 1-3) detected with the GFP probe. The genomic viral RNA (gRNA) was the least and the viral subgenomic (sg) of the rbcs cDNA was inserted into the GFP ORF ( Figure  4A ). These derivatives are collectively referred to as RNA1 was the most abundant. The sgRNA2 co-migrated with and could not be differentiated from the GFP trans-PVX-rbcs-X in which "X" indicates the various mutations carried by each individual construct ( Figure 4C ). The gene mRNA ( Figure 3D , left panel, tracks 1-4). At 2.5 dpi, these RNAs were all abundant in the PVX-GFPAgrobacterium infiltration procedure was used to inoculate these PVX constructs to non transgenic plants. Inoc-⌬12K-⌬CP, PVX-GFP-⌬8K-⌬CP and PVX-GFP-⌬25k-⌬CP-infected tissues. At 5dpi, however, with all three ulation of the PVX-rbcs-⌬TGB-⌬CP derivative led to systemic silencing of rbcs that was manifested as yel-TGB mutants, the levels of these RNA species were markedly reduced. This reduction was dependent on low-green chlorosis in and around the veins of systemic leaves ( Figure 4B ). In contrast to the extensive GFP the virus because, in mock inoculated tissue, the GFP mRNA was at the same level at 2.5 and 5dpi ( Figure 3D , silencing ( Figure 3B, panel 1) , the rbcs silencing remained restricted to the vicinity of the veins and was left panel, tracks 4 and 8). Thus, this change in RNA abundance was likely due to PTGS that was targeted only evident in leaves that emerged within 10-16 dpi. This phenotype was consistent with the lack of relayagainst both viral and transgene GFP RNA species (Figure 3D, Figure 3B, and 3C ). From these results we conclude that, of the PVX-encoded proteins, p25 was sufficient to interfere with systemic silencing of the GFP transgene.
Ectopic Expression of p25 and Local Silencing
The effect of p25 on systemic silencing could result from a block of signal production in the infiltrated cells. Alternatively, this protein could prevent movement of the signal out of the cells in which it was produced. To investigate these alternatives, we monitored the local effects of p25 on RNA levels and GFP fluorescence in the leaves where PTGS had been initiated. If signal movement was targeted, the local silencing in inoculated cells would be unaffected. However, an effect of p25 on signal production would likely affect initiation of local silencing.
By 5dpi, in leaves infiltrated with the (35S-25k-⌬ATGϩ35S-GFP) combination or with the 35S-GFP construct alone, there was loss of GFP fluorescence, as expected, indicating the onset of local PTGS (data not shown). Correspondingly, the levels of GFP RNAs in those tissues were lower than in mock-infiltrated tissues ( Figure 5C , tracks 2 and 3 compared with track 4) and the GFP 25nt antisense RNAs were abundant ( Figure  5D, tracks 2-3) .
In contrast, infiltration with the (35S-25kϩ35S-GFP) combination caused the green fluorescence to increase in the infiltrated leaf (data not shown). The GFP RNA was also much more abundant in those tissues than in the mock-infiltrated tissues, presumably because the integrated and the ectopic 35S-GFP transgenes were both expressed ( Figure 5C ( Figure 5D tracks 4 and 5) . Collectively, these results indicate that ectopic, constitutive expression of p25 prevented transgene-induced silencing of the GFP transgene in the infiltrated region. When the inducer of silencing was the replicating PVX-GFP-⌬25k-⌬CP construct, the effects of p25 were more complex. In the (PVX-GFP-⌬25k-⌬CPϩ35S-25k) samples, at 2.5dpi, the levels of all high molecular weight RNAs were substantially higher than in the control (Figure 5E, track 3 compared to track 1) . These data suggest that p25 caused suppression of PTGS at this early time point. However, by 5dpi, even in the presence of p25, the target RNAs had all declined to lower levels than at 2.5dpi ( Figure 5E, tracks 2 and 4) . The GFP mRNA from the transgene was masked by one of the viral subgenomic RNAs, but it was clearly less abundant than in the mock-infiltrated tissue ( Figure 5E , track 4 compared to track 5, sgRNA2 and GFP RNA). This decline in the levels of target RNAs was observed in at least three independent experiments and indicates that, between 2.5 and 5dpi, local PTGS triggered by PVX-GFP-⌬25k-⌬CP had overcome the initial effect of p25.
The failure of p25 to prevent PTGS in PVX-GFP-⌬25k-⌬CP-infiltrated tissues was confirmed by the analysis of 25nt GFP RNAs. At 5dpi, these RNAs were 2. In principle, these data could indicate that there are separate pathways, with multiple p25 targets, leading ing that this effect is specific for TEV. Conceivably, the products of RTM1 and RTM2 could affect the ability of to local and systemic silencing. We cannot rule out that possibility, although it seems unlikely, because it re-TEV to prevent systemic spread of the sequence-specific silencing signal (Chisholm et al., 2000) . Similarly, in quires that a virus-encoded protein would suppress the local PTGS induced by a transgene but not by a replicatthe many examples where viruses replicate efficiently ing virus. Instead, we favor an alternative explanation in which p25 has a single target required for both local and systemic silencing. According to this explanation, the systemic signal would be produced in the SDE1-dependent branch of the pathway and, therefore, would be a precursor of the 25nt RNAs ( Figure 6B ). This 'single target' explanation involves a refinement of the previous PTGS model ( Figure 6A ) in which the SDE1-dependent branch is not influenced by viruses. In the refined model (Figure 6B) , the virus-induced local PTGS would involve the SDE1-independent, p25-insensitive branch of the pathway, as previously. However, the SDE1-dependent, p25-sensitive branch is now recognized as being virus-induced ( Figure 6B) . As a result of this change, the model accommodates the finding that systemic signal production is influenced by PVX replication (Figure 4) and is suppressed by p25. A further attraction of this refined model is that it resolves an apparent discrepancy between our results with Sde1 and those of Mourrain et al., (2000) with Sgs2, which is identical to Sde1. In our analysis, we found that mutation of Sde1/Sgs2 does not affect susceptibility to tobacco mosaic virus, tobacco rattle virus and turnip crinkle virus (Dalmay et al., 2000) whereas Mourrain and colleagues found that mutations at this locus resulted in hypersusceptibility to CMV (Mourrain et al., 2000) . Presumably, the two sets of data differ because, of the viruses tested, CMV is the only one for which RNA accumulation is strongly limited by systemic PTGS. The other viruses are most likely limited by local PTGS which, as discussed above, is not dependent on Sde1. 
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